ResearcherPeople's Liberation Army Air ForceNo recent work listed
Chengli Liu
Matched on ORCID iD 0000-0002-9654-7486; OpenAlex author ID A5069200309. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2014: 3 papers · 2015: 3 papers
Papers 6
- Association between CLPTM1L-TERT rs401681 polymorphism and risk of pancreatic cancer: a meta-analysis. Co-author DOI 10.1007/s10238-014-0316-3↗
- TGFβ signaling in pancreatic ductal adenocarcinoma. First author DOI 10.1007/s13277-014-2757-4↗
- The influence of SnoN gene silencing by siRNA on the cell proliferation and apoptosis of human pancreatic cancer cells. Co-author DOI 10.1186/s13000-015-0267-3↗
- Association between OGG1 gene single nucleotide polymorphisms and risk of pancreatic cancer in Chinese. Co-author DOI 10.1007/s12032-014-0040-6↗
- Association between CLPTM1L-TERT rs401681 polymorphism and pancreatic cancer risk among Chinese Han population. Co-author DOI 10.1007/s13277-014-1711-9↗
- Involvement of ephrin receptor A4 in pancreatic cancer cell motility and invasion. Co-author DOI 10.3892/ol.2014.2011↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hongyi Zhang · 4 shared papers, 2014–2015 · strength 0.22
- Paper TGFβ signaling in pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-014-2757-4↗
- Paper The influence of SnoN gene silencing by siRNA on the cell proliferation and apoptosis of human pancreatic cancer cells. DOI 10.1186/s13000-015-0267-3↗
- Paper Involvement of ephrin receptor A4 in pancreatic cancer cell motility and invasion. DOI 10.3892/ol.2014.2011↗
- Hui Zhang · 2 shared papers, 2015 · strength 0.12
- Cheng Wang · 2 shared papers, 2014–2015 · strength 0.11
- Hongyi Zhang · 2 shared papers, 2014–2015 · strength 0.11
- Cheng Wang · 1 shared paper, 2015 · strength 0.06
- Hui Zhang · 1 shared paper, 2014 · strength 0.05
- Yingjie Wang · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.